Angst

Skapinakis et al 2016, Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis, Lancet Psychiatry 2016; 3: 730–39, http://dx.doi.org/10.1016/ S2215-0366(16)30069-4 

Leichsenring,og Leweke 2017; Social Anxiety Disorder, N Engl J Med 2017; 376:2255-2264 DOI: 10.1056/NEJMcp1614701 

Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. 2015 Feb;206(2):93-100. doi: 10.1192/bjp.bp.114.148551. PMID: 25644881.

Slee et al 2019, Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis, Lancet 2019 Feb 23;393(10173):768-777. doi: 10.1016/S0140-6736(18)31793-8. 

Gale et al 2016, Generalised anxiety disorder in children and adolescents, BMJ Clin Evid. 2016; 2016: 1002 

George et al 2016; Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder, J Trauma Dissociation, Jul-Sep 2016;17(4):494-510. doi: 10.1080/15299732.2016.1141150 

Skeie-Larsen M, Stave R, Grønli J, Bjorvatn B, Wilhelmsen-Langeland A, Zandi A, Pallesen S. The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials. Int J Environ Res Public Health. 2022 Dec 31;20(1):777. doi: 10.3390/ijerph20010777. PMID: 36613097; PMCID: PMC9820008.

Williams T, Phillips NJ, Stein DJ, et al. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2022 Mar 2;3:CD002795. doi: 10.1002/14651858.CD002795.pub3. 

Williams T, McCaul M, Schwarzer G, Cipriani A, Stein DJ, Ipser J. Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis. Acta Neuropsychiatrica. 2020;32(4):169-176. doi:10.1017/neu.2020.6 

Kong W, Deng H, Wan J, Zhou Y, Zhou Y, Song B and Wang X (2020) Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of DoubleBlind Randomized Controlled Trials. Front. Pharmacol. 11:580858. doi: 10.3389/fphar.2020.580858 

Guaiana G, Meader N, Barbui C, Davies SJC, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Pharmacological treatments in panic disorder in adults: a network meta‐analysis. Cochrane Database of Systematic Reviews 2023, Issue 11. Art. No.: CD012729. DOI: 10.1002/14651858.CD012729.pub3. 

Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM; the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26. PMID: 32098487. 

Fonseka LN, Woo BK. Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review. World J Psychiatry. 2023 May 19;13(5):182-190. doi: 10.5498/wjp.v13.i5.182. PMID: 37303932; PMCID: PMC10251361. 

Wang H, Jin M, Xie M, Yang Y, Xue F, Li W, Zhang M, Li Z, Li X, Jia N, Liu Y, Cui X, Hu G, Dong L, Wang G, Yu Q. Protective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trials. J Affect Disord. 2023 Feb 15;323:264-279. doi: 10.1016/j.jad.2022.11.072. Epub 2022 Nov 25. PMID: 36442656. 

Guaiana G, Meader N, Barbui C, Davies SJC,Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, TajikaA, Bighelli I, Pompoli A, Cipriani A, Dawson S, RobertsonL. Pharmacological treatments in panic disorder inadults: a network meta-analysis. Cochrane Database of SystematicReviews 2023, Issue 11. Art. No.: CD012729.DOI: 10.1002/14651858.CD012729.pub3.

Kong W, Deng H, Wan J, Zhou Y,Zhou Y, Song B and Wang X (2020) Comparative Remission Rates and-Tolerability of Drugs for Generalised AnxietyDisorder: A Systematic Review and Network Meta-analysis ofDoubleBlind Randomized Controlled Trials. Front. Pharmacol.11:580858. doi: 10.3389/fphar.2020.580858 

Slee A et al 2019,Pharmacological treatments for generalised anxiety disorder: a systematic review and networkmeta-analysis, Lancet 2019 Feb23;393(10173):768-777. doi: 10.1016/S0140-6736(18)31793-8. 

Williams T, Phillips NJ, Stein DJ, et al. Pharmacotherapy forpost traumatic stress disorder (PTSD). CochraneDatabase Syst Rev. 2022 Mar 2;3:CD002795. doi:10.1002/14651858.CD002795.pub3. 

Williams T, McCaul M, Schwarzer G, Cipriani A, Stein DJ, Ipser J. Pharmacologicaltreatments for social anxiety disorder in adults: a systematic review and network meta-analysis. Acta Neuropsychiatri-ca.2020;32(4):169-176. doi:10.1017/neu.2020.6 

Wang H et al. Protective role of antioxidant supplementation for depression and anxiety_A meta-analysis of randomized clinical trials. Journal of Affetive Disorders 2023, 323, 264-279. https://doi.org/10.1016/j.jad.2022.11.072